Labo Euromedis (FRA:61R) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:61R Labo Euromedis FRA:61R
61 GF Score
Price €4.76
GF Value €4.37
! 6 Warning Signs
View Full Analysis

What is Labo Euromedis FFO?

FFO (Funds from operations) only applies to REITs.

FRA:61R
61GF Score
Labo Euromedis FRA:61R
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Labo Euromedis (FRA:61R) Overvalued in 2026?

Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued. The current stock price of €4.76 is trading 8.9% above its estimated GF Value™ of €4.37.

Key valuation signals for FRA:61R:

  • FFO:
  • GF Value™: €4.37 vs. price of €4.76 (8.9% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the FRA:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Labo Euromedis Business Description

Address ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
61GF Score

Get the complete analysis for FRA:61R

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.76
Price
€4.37
GF Value